S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967688.12579.64 |
_version_ | 1827332468446855168 |
---|---|
author | Fritz Offner Olivier Decaux Cyrille Hulin Sébastien Anguille Anne Sophie Michallet Luciano Costa Cyrille Touzeau Kevin Boyd Deeksha Vishwamitra Yue Guo Zhuolu Niu Julie Larsen Lingling Chen Arnob Banerjee Jenna Goldberg Jeffrey Matous |
author_facet | Fritz Offner Olivier Decaux Cyrille Hulin Sébastien Anguille Anne Sophie Michallet Luciano Costa Cyrille Touzeau Kevin Boyd Deeksha Vishwamitra Yue Guo Zhuolu Niu Julie Larsen Lingling Chen Arnob Banerjee Jenna Goldberg Jeffrey Matous |
author_sort | Fritz Offner |
collection | DOAJ |
first_indexed | 2024-03-07T16:59:23Z |
format | Article |
id | doaj.art-d3a128ba2d614153859705738f388362 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T16:59:23Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-d3a128ba2d614153859705738f3883622024-03-03T03:25:45ZengWileyHemaSphere2572-92412023-08-017e125796410.1097/01.HS9.0000967688.12579.64202308003-00096S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDYFritz Offner0Olivier Decaux1Cyrille Hulin2Sébastien Anguille3Anne Sophie Michallet4Luciano Costa5Cyrille Touzeau6Kevin Boyd7Deeksha Vishwamitra8Yue Guo9Zhuolu Niu10Julie Larsen11Lingling Chen12Arnob Banerjee13Jenna Goldberg14Jeffrey Matous151 University Hospital Ghent, Ghent, Belgium2 Centre Hospitalier Universitaire de Rennes, Rennes, France3 Hôpital Haut Leveque, University Hospital, Pessac, France4 Vaccine and Infectious Disease Institute, University of Antwerp and the Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium5 Centre Hospitalier Lyon Sud, Hospices Civils, Pierre Bénite, France6 University of Alabama at Birmingham, Birmingham, United States7 Centre Hospitalier Universitaire de Nantes, Nantes, France8 The Royal Marsden Hospital, London, United Kingdom9 Janssen Research & Development, Spring House, United States9 Janssen Research & Development, Spring House, United States10 Janssen Research & Development, Shanghai, China11 Janssen Research & Development, Los Angeles, United States9 Janssen Research & Development, Spring House, United States9 Janssen Research & Development, Spring House, United States12 Janssen Research & Development, Raritan, United States13 Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000967688.12579.64 |
spellingShingle | Fritz Offner Olivier Decaux Cyrille Hulin Sébastien Anguille Anne Sophie Michallet Luciano Costa Cyrille Touzeau Kevin Boyd Deeksha Vishwamitra Yue Guo Zhuolu Niu Julie Larsen Lingling Chen Arnob Banerjee Jenna Goldberg Jeffrey Matous S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY HemaSphere |
title | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
title_full | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
title_fullStr | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
title_full_unstemmed | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
title_short | S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY |
title_sort | s194 teclistamab tec nirogacestat niro in relapsed refractory multiple myeloma rrmm the phase 1b majestec 2 study |
url | http://journals.lww.com/10.1097/01.HS9.0000967688.12579.64 |
work_keys_str_mv | AT fritzoffner s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT olivierdecaux s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT cyrillehulin s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT sebastienanguille s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT annesophiemichallet s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT lucianocosta s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT cyrilletouzeau s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT kevinboyd s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT deekshavishwamitra s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT yueguo s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT zhuoluniu s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT julielarsen s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT linglingchen s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT arnobbanerjee s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT jennagoldberg s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study AT jeffreymatous s194teclistamabtecnirogacestatniroinrelapsedrefractorymultiplemyelomarrmmthephase1bmajestec2study |